Madrigal (MDGL) Reports Q1 Loss, Beats Revenue Estimates

Madrigal (MDGL) came out with a quarterly loss of $3.25 per share versus the Zacks Consensus Estimate of a loss of $3.61. This compares to a loss of $3.32 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +9.97%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $0.04 per share when it actually produced a loss of $2.57, delivering a surprise of -6525%.Over the last four quarters, the compa ...

Madrigal Pharmaceuticals-Madrigal (MDGL) Reports Q1 Loss, Beats Revenue Estimates - Reportify